FDA Warning Letter: EzriCare LLC
type: Action
additional type: https://schema.org/RegulationAction
start time: 2024-02-27
description: CGMP/Finished Pharmaceuticals/Adulterated. Issued by FDA Division of Pharmaceutical Quality Operations I on 2024-02-13.
agent: FDA Division of Pharmaceutical Quality Operations I
object: EzriCare LLC
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters
source organization: U.S. Food and Drug Administration
publisher: AI Analytics

PropertyValue
property ID: FDA Warning Letter ID
value: 8b774081ad000a03

AI Analytics
type: Organization